Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-11-19, Stock:PFE, The news for the past five days is as follows:
2021-11-12: NEWS1: One in three Americans aged 65 and above has got COVID-19 booster shot: CDC.NEWS2: Best way to minimize COVID-19 risk this holiday season is by getting vaccinated: Doctor.NEWS3: Some states expand booster availability beyond federal recommendations.NEWS4: Johnson & Johnson Pops As It Announces The Biggest Split In Health Care.NEWS5: Moderna vaccine patent dispute: 'It’s a political story. It’s a financial story. It’s a legal story’.NEWS6: Coronavirus: Doctor sees ‘beginning of a wave’ as winter looms.NEWS7: Doctor's holiday gathering advice amid pandemic: 'Being vaccinated goes a long way'.NEWS8: UPDATE 1-WHO to set guidelines on COVID-19 antiviral pills soon.NEWS9: The Johnson & Johnson split ‘makes sense’ as it moves into ‘more innovative products’: Analyst.NEWS10: AstraZeneca has decided to make money from the pandemic after all.NEWS11: Johnson & Johnson Stock Is Gaining Because 2 Companies Might Make More Sense Than 1.NEWS12: Pre-Markets Edge Up on JNJ Split News.NEWS13: Johnson & Johnson Stock Rises on Plan for Breakup.NEWS14: Johnson & Johnson CFO: Splitting company into two is about 'the potential unlocking of value for the consumer health business'.NEWS15: J&J Plans to Split in Two; Dow Up Triple Digits.NEWS16: Johnson & Johnson  to split into two companies, consumer products and medical devices.NEWS17: Johnson & Johnson Stock Jumps on Plan for Breakup.NEWS18: Pharma Stock Roundup: AZN, BAYRY Q3 Results, PFE COVID Pill's Strong Efficacy.NEWS19: 3 Pharma Stocks That Could Make You Richer in November (and Beyond).NEWS20: J&J Pops on Decision to Split Consumer Health Business.NEWS21: AstraZeneca Slips on Q3 Miss, Intends to Start Marking up Covid Vaccine Price.
2021-11-15: NEWS1: Vaccines sent to some of the 'hardest to reach' places with Zipline drone delivery.NEWS2: Covid Cases Are Rising Again. Booster Rollout Could Expand as a Result..NEWS3: India's Dr. Reddy's open to making Pfizer COVID pill after Merck deal.NEWS4: Ascendis (ASND) Gets Positive CHMP Opinion for GHD Drug Filing.NEWS5: J&J (JNJ) to Separate Consumer Unit Into New Company, Stock Up.NEWS6: 4 Stocks Insiders Are Selling.NEWS7: Britain to extend COVID booster rollout to over-40s.NEWS8: Pfizer’s Big Gamble Is Paying Off. Its Stock Is a Good Long-Term Bet..NEWS9: Will Johnson & Johnson’s Split Pay Off? History Says No..
2021-11-16: NEWS1: Regulators closer to approving COVID booster for all adults.NEWS2: UPDATE 1-FDA promises quick review of Pfizer booster for all adults, CDC meets Friday.NEWS3: Atea Pharma Stock Collapses As Roche Pulls The Plug On Pfizer-Rivaling Covid Pill.NEWS4: UPDATE 1-Pfizer files for U.S. authorization of promising COVID-19 antiviral pill.NEWS5: CDC advisers to review data on wider use of Pfizer-BioNTech COVID-19 vaccine.NEWS6: Pfizer COVID-19 pill set to be 'huge' help in pandemic fight, says doctor.NEWS7: Pfizer Asks FDA To Authorize Its Merck-Rivaling Covid Pill; Shares Inch Down.NEWS8: Pfizer seeks emergency use authorization for its COVID-19 pill.NEWS9: Pfizer Submits Covid-19 Pill for FDA Authorization.NEWS10: Vaccines combatting coronavirus ‘should not be a politicized topic,’ doctor urges.NEWS11: U.S. administers 443.4 mln doses of COVID-19 vaccines - CDC.NEWS12: COVID-19 booster shots are 'going to be the norm,' NewYork-Presbyterian Hospital CEO explains.NEWS13: Pfizer files for U.S. regulatory authorization of its COVID pill.NEWS14: Pfizer files for U.S. authorization of COVID-19 pill.NEWS15: Pfizer Seeks Emergency Use Authorization for Novel COVID-19 Oral Antiviral Candidate.NEWS16: UPDATE 1-U.S. expected to purchase 10 mln courses of Pfizer COVID-19 pill - WaPo.NEWS17: S&P 500 Closes Just Shy of Record High as Tech, Retailers Shine.NEWS18: Pfizer and Moderna announce moves to help get vital COVID medicines to low-income countries, and Arkansas joins U.S. states expanding booster program to all adults.NEWS19: 4 Reasons Why You Should Add Glaxo (GSK) to Your Portfolio.NEWS20: S&P 500 Sets Sights on Record High as Retailers Rally.NEWS21: Pfizer Applies to FDA for Authorization of Anti-Covid Pill.NEWS22: Pfizer Signs Royalty-Free Deal to Aid Poor Nations’ Access to Its Covid Pill.NEWS23: UPDATE 1-Pfizer to allow generic versions of its COVID pill in 95 countries.NEWS24: Dr. Reddy's Ready To Make COVID-19 Antiviral From Pfizer - Reuters.NEWS25: UPDATE: Pfizer to allow generics companies to make its COVID-19 oral antiviral treatment, expand access to poorer countries.NEWS26: REFILE-Pfizer to allow generic versions of its COVID-19 pill in 95 countries.NEWS27: Pfizer and The Medicines Patent Pool (MPP) Sign Licensing Agreement for COVID-19 Oral Antiviral Treatment Candidate to Expand Access in Low- and Middle-Income Countries.NEWS28: Biden’s Inflation Solution May Be Staring Him in the Face—China.NEWS29: REFILE-Pfizer to conduct trials of antiviral COVID-19 pill in Russia.NEWS30: Walmart, Home Depot Rise Premarket; Tesla, Pfizer Fall.NEWS31: Pfizer Agrees to Allow for Generic Production of Its COVID-19 Pill.NEWS32: Pfizer Falls on Deal With UN-Backed Body to Sell Covid Drug Sans Royalty.
2021-11-17: NEWS1: Why Pfizer Rose While the Market Sank on Wednesday.NEWS2: U.S. administers nearly 445 mln doses of COVID-19 vaccines - CDC.NEWS3: Pfizer Stock Gaps Higher On Covid Pill Enthusiasm — Is It A Buy Now?.NEWS4: 'There will be another pandemic' and we need to be prepared when it comes: Doctor.NEWS5: UPDATE 1-Moderna seeks U.S. authorization of COVID-19 vaccine boosters for all adults.NEWS6: Stocks: Travel and crypto dip, retail rallies, pharmaceuticals rise.NEWS7: UK health agency extends gap between infection and shots for children.NEWS8: Pfizer launches search for new CFO as Frank D'Amelio announces his retirement.NEWS9: Atea (AVIR) Plunges on Termination of Collaboration With Roche.NEWS10: Pfizer, EV Stocks, Oil Industry: 3 Things to Watch.NEWS11: Pfizer (PFE) Seeks FDA's Emergency Use Nod for COVID Pill.NEWS12: Are You a Value Investor? This 1 Stock Could Be the Perfect Pick.NEWS13: 3 Big Pharma Outperformers to Watch Out For in the Near Term.NEWS14: Pfizer Files For FDA Emergency Use Nod For Its COVID-19 Antiviral Pill.NEWS15: FDA Plans Quick Review of Pfizer/BioNTech COVID-19 Booster For All Adults: NYT.NEWS16: Pfizer Completes Acquisition of Trillium Therapeutics.NEWS17: UPDATE 2-Pfizer CFO D'Amelio to retire after 15 years at company.NEWS18: Pfizer CFO D'Amelio to retire after 15 years at company.NEWS19: Coronavirus tally: Global cases of COVID-19 above 254.5 million and FDA may authorize boosters for all adults by Thursday.NEWS20: Pfizer Announces Retirement of Chief Financial Officer Frank D’Amelio.NEWS21: Nvidia Earnings Are a Big Deal. But There’s Something More Important..NEWS22: Will Investors Win With Johnson & Johnson's Planned Spinoff? Here's What History Shows.NEWS23: EU watchdog to announce view on vaccine for children next week- Austria.NEWS24: Visa Weighs On Dow, Target Slumps, Lowe's Leaps - Stock Market Live.NEWS25: Target, Visa, Biogen Fall Premarket; Lowe's Rises.NEWS26: Target, Visa, Tesla, Pfizer and Lucid Active, Stocks Steady Amid Inflation Worries.NEWS27: Pfizer Stock Active After CFO Retirement, FDA Application For COVID Pill Approval.NEWS28: Pfizer Gains as Vaccine Booster for All Adults Nears Nod.NEWS29: Imugene Announces Clinical Trial Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate HER-Vaxx in Combination with Avelumab for Treatment of Gastric Cancer.NEWS30: Tesla, Pfizer, Visa, Qualcomm & Stock Markets - 5 Things You Must Know.
2021-11-18: NEWS1: UPDATE 1-Canada to authorize use of Pfizer's COVID-19 vaccine for children -source.NEWS2: Pfizer CEO Talks About Covid Vaccines and What Comes Next: ‘I Think We Are Undervalued.’.NEWS3: Why Cardiff Oncology Shares Were Up More Than 15% on Thursday.NEWS4: 'Everyone is a little bit confused' about COVID-19 vaccine mandates and rules: Doctor.NEWS5: Pfizer’s XELJANZ® (tofacitinib) Receives Marketing Authorization in the European Union for the Treatment of Active Ankylosing Spondylitis.NEWS6: FDA reviews mRNA booster shots for all adults ahead of holiday travel.NEWS7: Face masks and distancing are most effective measures in reducing COVID-19 spread, study finds, as experts clamor for U.S. to expand booster program.NEWS8: Pfizer Again, Macy's, GlobalFoundries: 3 Things to Watch.NEWS9: U.S. Buys 10 Million Treatment Courses of Pfizer’s Covid-19 Pill for $5.29 Billion.NEWS10: Pharma Stock Roundup: JNJ to Spin Off Consumer Unit, PFE Eyes EUA for COVID Pill.NEWS11: Pfizer to Be Paid $5.29 Billion From U.S. Government for Covid-19 Oral Pill.NEWS12: CureVac's COVID-19 Vax Shows Comparable Antibody Levels To Pfizer/BioNTech's Shot In Animal Study.NEWS13: EU drug regulator aims to conclude Merck COVID-19 antiviral pill approval by the end of 2021.NEWS14: Italy to acquire 50,000 courses for each of Merck, Pfizer COVID-19 antiviral drugs.NEWS15: Cardiff Oncology Stock Rises After $15M Equity Investment From Pfizer.NEWS16: Pfizer to supply U.S. government with 10 million doses of its antiviral for $5.29 billion.NEWS17: These 3 High-Yield Dividend Stocks Are Growing at Blazing Speeds.NEWS18: CureVac Stock Climbs as Early Data Show Hope for Second Try at Covid Vaccine.NEWS19: The Zacks Analyst Blog Highlights: Eli Lilly, Pfizer and Novo Nordisk.NEWS20: Pfizer seeks emergency U.S. authorization for 10 million doses of new COVID-19 anti viral drug.NEWS21: Cardiff Oncology Announces $15 Million Equity Investment from Pfizer through its Pfizer Breakthrough Growth Initiative.NEWS22: UPDATE 5-U.S. to buy 10 mln courses of Pfizer's COVID-19 pill for $5.3 bln.NEWS23: Should Pfizer Investors Expect a Big Dividend Hike in 2022?.NEWS24: Pfizer to Provide U.S. Government with 10 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-19.NEWS25: Pfizer Gains on $5.29 Billion Deal with U.S. for Covid-19 Pill.NEWS26: AstraZeneca Says Preventive Covid Antibody Drug Reduces Risk by 83%.NEWS27: Pfizer Stock Gains On $5.3 Billion COVID Pill Treatment Deal With US Government.NEWS28: Companies make progress tackling drug-resistant infections, foundation says.

Answer: Decrease